{
    "clinical_study": {
        "@rank": "144583", 
        "arm_group": [
            {
                "arm_group_label": "semi-quantitative procalcitonin", 
                "arm_group_type": "Experimental", 
                "description": "patients whom checked semi-quantitative procalcitonin examination"
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "No Intervention", 
                "description": "patients whom do not checked semi-quantitative procalcitonin examination"
            }
        ], 
        "brief_summary": {
            "textblock": "Sepsis is a serious clinical condition with a considerable morbidity and mortality.\n      Procalcitonin (PCT) is a good biomarker for early diagnosis and infection monitoring. The\n      present study aimed to investigate the effect of semi-quantitative PCT test to the empirical\n      antibiotic initiation time, the appropriateness of empirical antibiotics and mortality in\n      septic patients.\n\n      The hypothesis of the study are :\n\n        -  There is an effect on mortality between septic patients who do and do not do\n           semi-quantitative PCT examination\n\n        -  There is an effect on empirical antibiotic initiation time between septic patients who\n           do and do not do semi-quantitative PCT examination\n\n        -  There is an effect on appropriateness of empirical antibiotic between septic patients\n           who do and do not do semi-quantitative PCT examination\n\n      Study design is randomized diagnostic trial which is also a pragmatic trial."
        }, 
        "brief_title": "The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Sepsis", 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  aged more than 18 years old\n\n          -  have at least two concomitant systemic inflammatory response syndrome criteria\n\n          -  have focal infection\n\n          -  with or without sign of organ hypoperfusion or dysfunction\n\n        Exclusion Criteria:\n\n          -  post operative patient\n\n          -  trauma patient\n\n          -  have obtained prior antibiotic\n\n          -  refused to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "205", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01862185", 
            "org_study_id": "AB-PCTQ1"
        }, 
        "intervention": {
            "arm_group_label": "semi-quantitative procalcitonin", 
            "intervention_name": "semi-quantitative procalcitonin", 
            "intervention_type": "Other", 
            "other_name": "PCT-Q"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "semiquantitative", 
            "procalcitonin", 
            "sepsis", 
            "antibiotics", 
            "mortality"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jakarta", 
                    "country": "Indonesia", 
                    "state": "DKI Jakarta", 
                    "zip": "10430"
                }, 
                "name": "Cipto Mangunkusumo Hospital"
            }
        }, 
        "location_countries": {
            "country": "Indonesia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pengaruh Pemeriksaan Procalcitonin Semikuantitatif Terhadap Adekuasi Terapi Antibiotik Empirik Awal Dan Mortalitas Pada Pasien Sepsis", 
        "overall_official": {
            "affiliation": "Faculty of Medicine, Indonesia University", 
            "last_name": "Dana Dharaniyadewi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Indonesia: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "mortality in 14 days since the patients were included in this study", 
            "measure": "mortality rate", 
            "safety_issue": "No", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01862185"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Indonesia University", 
            "investigator_full_name": "Dana Dharaniyadewi", 
            "investigator_title": "student", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "when does the patient get their first dose of empirical antibiotic in 24 hours since the patient was diagnosis as sepsis?", 
                "measure": "the timing of empirical antibiotic first dose", 
                "safety_issue": "No", 
                "time_frame": "in 24 hours since the patient was diagnosis as sepsis"
            }, 
            {
                "description": "does the empirical antibiotic that given in 24 hours since the patient was diagnosis as sepsis is effective?", 
                "measure": "the appropriateness of empirical antibiotic", 
                "safety_issue": "No", 
                "time_frame": "in 24 hours since the patient was diagnosed as sepsis"
            }
        ], 
        "source": "Indonesia University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Indonesia University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}